Since inflammation is known to be a significant contributor to the pathogenesis of cardiovascular disease, we studied the number and function of a novel subset of regulatory T cells, termed CD4+LAP+ Tregs, in patients with ACS. This evidence concerns the gene CD4 and cardiovascular disorder.